Jana Kotaskova

8PUBLICATIONS
73CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 19, 2026
High-risk genomic features predict extramedullary progression in multiple myeloma with paraskeletal plasmacytomas.

|Apr 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

Birna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton

|May 21, 2024
Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing.

Terezia Kurucova, Kamila Reblova, Pavlina Janovska

|Dec 08, 2023
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients.

Veronika Navrkalova, Karla Plevova, Lenka Radova

|Jan 12, 2023
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.

Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton

|Dec 24, 2022
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.

Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton

Pageof 2

Frequent Collaborators

5 joint publications

Sarka Pospisilova

4 joint publications

Sarka Pavlova

4 joint publications

Michael Doubek

4 joint publications

Karla Plevova